# GTP Regimen in the Treatment of Refractory/Recurrent HLH

> **NCT06038422** · PHASE3 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Refractory
- Recurrence
- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** GTP regimen

## Key facts

- **NCT ID:** NCT06038422
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-15
- **Primary completion:** 2024-09-15
- **Final completion:** 2025-09-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038422, "GTP Regimen in the Treatment of Refractory/Recurrent HLH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06038422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*